Newsroom

Sorted by: Latest
-

iQmetrix annonce le tout premier « Sommet du commerce de détail des télécoms » au MWC Barcelone 2026

BARCELONE, Espagne--(BUSINESS WIRE)--iQmetrix, unique fournisseur mondial de solutions de commerce interconnecté pour le commerce de détail des télécoms, a annoncé aujourd'hui son retour au Mobile World Congress (MWC) de Barcelone avec le tout premier Sommet du commerce de détail des télécoms. Ce sommet exclusif d'une demi-journée a pour but de susciter un débat qui n'a que trop tardé : le secteur des télécoms vend la technologie la plus avancée au monde, mais offre l'une des expériences de ven...
-

Riassunto: iQmetrix annuncia il primo "Telecom Retail Summit" al MWC Barcelona 2026

BARCELLONA, Spagna--(BUSINESS WIRE)--iQmetrix, l'unico fornitore globale di soluzioni di commercio interconnesso per la vendita al dettaglio nel settore delle telecomunicazioni, oggi ha annunciato il suo ritorno al Mobile World Congress (MWC) Barcelona con il primo Telecom Retail Summit . L'esclusivo summit di mezza giornata, ideato per stimolare una conversazione da troppo tempo attesa: il settore delle telecomunicazioni vende la tecnologia più avanzata sul pianeta, eppure offre una delle espe...
-

iQmetrix kündigt den ersten „Telecom Retail Summit“ auf dem MWC Barcelona 2026 an

BARCELONA, Spanien--(BUSINESS WIRE)--iQmetrix, der einzige globale Anbieter von Interconnected Commerce-Lösungen für den Telekommunikationshandel, gab heute seine Rückkehr zum Mobile World Congress (MWC) in Barcelona mit dem ersten Telecom Retail Summit bekannt. Der exklusive halbtägige Gipfel soll eine längst überfällige Diskussion anstoßen: Die Telekommunikationsbranche vertreibt die fortschrittlichsten Technologien der Welt, bietet jedoch eines der am wenigsten inspirierenden Einkaufserlebni...
-

Securities Fraud Investigation Into Telesat Corporation (TSAT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Telesat Corporation ("Telesat " or the Company") (NASDAQ: TSAT) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TELESAT CORPORATION (TSAT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On January 21, 2026, bondholders filed a lawsuit against Telesat...
-

Rosen Law Firm Encourages Nutanix, Inc. Investors to Inquire About Securities Class Action Investigation – NTNX

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Nutanix, Inc. (NASDAQ: NTNX) resulting from allegations that Nutanix may have issued materially misleading business information to the investing public. So What: If you purchased Nutanix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
-

GlobalAir.com Partners With AERO Friedrichshafen to Develop Pre-Owned Aircraft Area

LOUISVILLE, Ky.--(BUSINESS WIRE)--GlobalAir.com has been named the official sales representative for the pre-owned aircraft market at AERO Friedrichshafen....
-

A Concept Medical anuncia a inclusão do primeiro paciente no estudo clínico randomizado STARS DAPT, que avalia o stent farmacológico sem polímero Abluminus NP

TAMPA, Flórida--(BUSINESS WIRE)--A Concept Medical Inc., pioneira global em tecnologia inovadora de administração de medicamentos, tem o orgulho de anunciar a inclusão bem-sucedida do primeiro paciente no estudo clínico randomizado e controlado STARS DAPT (ST-Infarto do miocárdio com elevação do segmento ST tratado com um stent farmacológico sem polímero, com liberação de sirolimus por nanocarreador, e uma estratégia de terapia antiplaquetária única baseada em inibidor de P2Y12 após um curto pe...
-

Concept Medical inscribe los primeros pacientes en el ensayo clínico aleatorizado STARS DAPT, que evalúa el stent liberador de medicamentos sin polímeros Abluminus np

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., pionera mundial en tecnología innovadora para la administración de medicamentos, se enorgullece de anunciar la incorporación satisfactoria de los primeros pacientes al estudio STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latele...
-

Samenvatting: Concept Medical kondigt de registratie aan van de eerste patiënten in de STARS DAPT gerandomiseerde klinische studie waarin Abluminus NP polymeervrije DES wordt beoordeeld

TAMPA, Fla.--(BUSINESS WIRE)--Concept Medical Inc., een wereldwijde pionier in innovatieve technologie voor toediening van geneesmiddelen, kondigt trots de succesvolle registratie aan van de eerste patiënten in de STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction (= myocardinfarct met ST-segmentstijging) behandeld met een polymeervrije, op sirolimus gebaseerde nanocarrie R eluting stent en een op P2Y12 remmer gebaseerde S ingle Antiplatelet Strategie na een korte Dual Antiplatelet Ther...
-

Concept Medical kündigt die erste Patientenaufnahme in die randomisierte klinische Studie STARS DAPT zur Bewertung des Abluminus NP polymerefreien DES an

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., ein globaler Pionier auf dem Gebiet innovativer Wirkstofffreisetzungstechnologien, freut sich, die erfolgreiche Aufnahme der ersten Patienten in die randomisierte kontrollierte STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latel...